Cordis US Corp. · Vascular Hemostasis/Closure Device · First cleared Aug 2005
Total Reports
261
Reports (30d)
9
Active Signals
1
Open Recalls
0
What the reports describe · Claripulse analysis
Closure Failure with Manual Compression Required
returned evaluation, device vcd, mynx control, mynx, sealant
20
reports
Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.
Detection
Evidence
Evaluation of the MYNX CONTROL™ Arterial Closure System for Achieving Primary Hemostasis after Arterial Femoral Access Following Peripheral Arterial Interventions, Compared to the FemoSealTM Closure System.
Noory E, et al. · 2023
Imaging-Guided Deployment of a Balloon-Based Vascular Closure Device in Routine Clinical Practice.
Lee WH, et al. · 2022
Utilisation of Image Guidance to Enhance Safety of Deployment of the Mynx Control Vascular Closure Device.
Dolan SG, et al. · 2021
Citations indexed from PubMed.
Keep exploring
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,504 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,336 reports
PERCLOSE
ABBOTT VASCULAR INC. · 9,890 reports
Angio-Seal
TERUMO MEDICAL CORPORATION · 6,417 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 5,991 reports
Resolute Onyx
MEDTRONIC, INC. · 4,467 reports
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 1 active signal detected right now.
Get Early AccessUnderstanding this data
